California State Teachers Retirement System (CalSTRS)’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio ONCT Stock Details ONCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-945	Closed	-$26K	–	3364
2022 Q1	$26K	Sell	945 -246	-21%	-$8.95K	﹤0.01%	3152
2021 Q4	$54K	Hold	1,191	–	–	﹤0.01%	3148
2021 Q3	$99K	Sell	1,191 -1,865	-61%	-$154K	﹤0.01%	3007
2021 Q2	$290K	Buy	+3,056	New	+$363K	﹤0.01%	2917
2019 Q2	–	Sell	-56	Closed	-$9K	–	3096
2019 Q1	$9K	Sell	56 -154	-73%	-$23K	﹤0.01%	2992
2018 Q4	$23K	Buy	210 +155	+282%	+$31K	﹤0.01%	3015
2018 Q3	$12K	Buy	55 +5	+10%	+$12K	﹤0.01%	3033
2018 Q2	$108K	Buy	+50	New	+$127K	﹤0.01%	2985
2014 Q2	–	Sell	-34	Closed	-$72K	–	3091
2014 Q1	$72K	Hold	34	–	–	﹤0.01%	3009
2013 Q4	$78K	Hold	34	–	–	﹤0.01%	2993
2013 Q3	$95K	Buy	34 +1	+3%	+$4.98K	﹤0.01%	2976
2013 Q2	$302K	Buy	+33	New	+$254K	﹤0.01%	2610

Other funds holding ONCT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

QPW

Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return

BJL

Brighton Jones LLC Seattle, Washington $4.53B AUM 21.1% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s ONCT Position: Q2 2022 in Review

California State Teachers Retirement System (CalSTRS) sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q2 2022, closing a stake of 945 shares — an estimated $26K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in ONCT in Q2 2013 and held it in 12 quarters. The position peaked at $302K in Q2 2013. 75 funds tracked by Wall St. Rank hold ONCT as of Q2 2022.

California State Teachers Retirement System (CalSTRS) reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
California State Teachers Retirement System (CalSTRS) sold 945 Oncternal Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $26K.
California State Teachers Retirement System (CalSTRS) first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q2 2013 and held it in 12 quarters.
California State Teachers Retirement System (CalSTRS)'s Oncternal Therapeutics, Inc. Common Stock position peaked at $302K in Q2 2013.
75 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q2 2022.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2022, filed 15 Aug 2022.